Effects of Drug Burden Index on Cognitive Function in Older Men
- 1 April 2012
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Clinical Psychopharmacology
- Vol. 32 (2), 273-277
- https://doi.org/10.1097/jcp.0b013e3182487825
Abstract
We aimed to assess the relationship between Drug Burden Index (DBI), a risk assessment tool that measures anticholinergic and sedative medication exposure and cognitive performance, and cognitive impairment in older people. The study population consisted of community-dwelling older men, 70 years or older, living in Sydney, Australia. The Addenbrooke's Cognitive Examination (ACE) and the Trail Making Task (TMT) cognitive tests were performed, and participants were categorized as having intact cognition, mild cognitive impairment, or dementia using clinical diagnostic criteria. The analyses were restricted to participants with English-speaking background (n = 987) and to the subgroup whose cognition was intact (n = 887). In the study group, DBI exposure was not associated with poorer performance on the ACE (odds ratio [OR], 0.98; 95% confidence interval [CI], 0.66-1.47) or the TMT (OR, 0.71; 95% CI, 0.40-1.24) tests, after controlling for covariates. Similarly, DBI exposure was not associated with cognitive impairment (OR, 1.34; 95% CI, 0.83-2.16). There was no association between increasing DBI scores and poorer performance on any of the outcomes. On subgroup analysis of cognitively intact subgroup, DBI exposure or increasing DBI scores were not associated with poorer performance on the ACE or the TMT tests. In this study of community-dwelling older men, DBI was not associated with limitations on objective cognitive performance measures or with a clinical diagnosis of mild cognitive impairment or dementia.Keywords
This publication has 35 references indexed in Scilit:
- Drugs With Anticholinergic Properties, Cognitive Decline, and Dementia in an Elderly General PopulationArchives of Internal Medicine, 2009
- Cumulative Anticholinergic Exposure Is Associated with Poor Memory and Executive Function in Older MenJournal of the American Geriatrics Society, 2008
- Impact of anticholinergics on the aging brain: a review and practical applicationAging Health, 2008
- Serum anticholinergic activity and motor performance in elderly persons.The Journals of Gerontology: Series A, 2007
- Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort studyBMJ, 2006
- Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID StudyBritish Journal of Clinical Pharmacology, 2004
- Serum Anticholinergic Activity in a Community-Based Sample of Older AdultsArchives of General Psychiatry, 2003
- Long-Term Benzodiazepine Use and Cognitive Decline in the Elderly: The Epidemiology of Vascular Aging StudyJournal of Clinical Psychopharmacology, 2002
- Pharmacokinetic-Pharmacodynamic Relationships For BenzodiazepinesClinical Pharmacokinetics, 1996
- Adverse Drug Reactions Associated with Global Cognitive Impairment in Elderly PersonsAnnals of Internal Medicine, 1987